Literature DB >> 12423654

Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers.

T Ashikaga1, M Hoya, H Itagaki, Y Katsumura, S Aiba.   

Abstract

The aim of this study was to explore the usefulness of a human monocyte cell line in the development of in vitro models for predictive testing of contact sensitizers. Several studies have shown that contact sensitizers induce CD86 expression and enhanced internalization of MHC class II molecules in dendritic cells (DCs). We used THP-1, a human monocyte cell line, as a replacement for DCs for evaluation of these phenotypical alterations as predictive endpoints for contact sensitizers. Known sensitizers and irritants were evaluated. After 24-h exposure to samples, the expression of CD86 on THP-1 cells was measured by flow cytometry. Sensitizers such as dinitrochlorobenzene (DNCB), 2-mercaptobenzothiazole (MBT), eugenol, p-phenylenediamine (PPDA) and ammonium tetrachloroplatinate (Pt) enhanced CD86 expression on THP-1 cells, while nickel sulfate, cobalt sulfate and irritants such as methylsalicylate (MS), sodium dodecyl sulfate (SDS) and dimethyl sulfoxide (DMSO) did not augment CD86 expression. A synergistic effect was observed when DNCB and IFN-alpha were added simultaneously to a culture of THP-1 cells. Furthermore, internalization of MHC class II molecules was observed when the cells were treated with some of sensitizers for 2 h. The inducing effects of chemicals on the two phenotypical alterations were the same. These results suggest that these test systems can be used to predict contact-sensitizing ability of chemicals as an in vitro sensitization assay.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423654     DOI: 10.1016/s0887-2333(02)00060-7

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals.

Authors:  Seyoum Ayehunie; Maureen Snell; Matthew Child; Mitchell Klausner
Journal:  Toxicology       Date:  2009-08-07       Impact factor: 4.221

Review 2.  Application of proteomics in the elucidation of chemical-mediated allergic contact dermatitis.

Authors:  Tessa Höper; Franz Mussotter; Andrea Haase; Andreas Luch; Tewes Tralau
Journal:  Toxicol Res (Camb)       Date:  2017-06-13       Impact factor: 3.524

Review 3.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

4.  Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells.

Authors:  Kristina Larsson; Malin Lindstedt; Carl A K Borrebaeck
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

5.  Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells.

Authors:  Sarah Kado; W L William Chang; Aimy Nguyen Chi; Monika Wolny; David M Shepherd; Christoph F A Vogel
Journal:  Arch Toxicol       Date:  2016-10-25       Impact factor: 5.153

6.  Biodegradable Polymers Induce CD54 on THP-1 Cells in Skin Sensitization Test.

Authors:  Yeon Suk Jung; Reiko Kato; Toshie Tsuchiya
Journal:  Int J Biomater       Date:  2011-08-02

7.  SkinSensDB: a curated database for skin sensitization assays.

Authors:  Chia-Chi Wang; Ying-Chi Lin; Shan-Shan Wang; Chieh Shih; Yi-Hui Lin; Chun-Wei Tung
Journal:  J Cheminform       Date:  2017-01-31       Impact factor: 5.514

Review 8.  GINIplus and LISAplus - Design and selected results of two German birth cohorts about natural course of atopic diseases and their determinants.

Authors:  J Heinrich; I Brüske; C Cramer; U Hoffmann; M Schnappinger; B Schaaf; A von Berg; D Berdel; U Krämer; I Lehmann; O Herbarth; M Borte; A Grübl; C P Bauer; C Beckmann; H Behrendt; J Ring; S Koletzko
Journal:  Allergol Select       Date:  2017-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.